1362. A Novel Intravesical Antimicrobial for CAUTIs
نویسندگان
چکیده
منابع مشابه
1362 Spray Combustion
The effect of fuel properties on the structure of swirling spray flames has been investigated. Droplet size, number density and velocity measurements have been carried out in pressureatomized spray flames using phase/Doppler interferometry. Four fuels with different physical properties were studied, namely n-heptane, methanol, 50/50 methanol/1-dodecanol mixture, and kerosene. The results indica...
متن کاملOp-cbio140031 1354..1362
Motivation: Rapid advances in next-generation sequencing (NGS) technology have led to exponential increase in the amount of genomic information. However, NGS reads contain far more errors than data from traditional sequencing methods, and downstream genomic analysis results can be improved by correcting the errors. Unfortunately, all the previous error correction methods required a large amount...
متن کامل1362 Connective Tissue Activation
14 C-gldcommine and '5S04-labeled glycosaminoglycan (GAG) synthesis, 2) responsiveness to autacdid mediators, and 3) perfarmance following maximal stimulation. Under basal conditions, SF synthesized and secreted 2-3 times more radioactive hyaluronic acid than the NF (P < 0.001); molecular volume by gel chromatography was similar and suggested a high molecular weight ptoduct. SF were essentially...
متن کاملResearch on Novel Intravesical Drug Delivery Devices
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creative-commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution , and reproduction in any medium, provided the original work is properly cited. Urologists usually treat overactive bladder (OAB) with oral medications. However, when th...
متن کاملDalbavancin: a novel antimicrobial
The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral administration of antimicrobials has inspired the development of a novel antibiotic. Dalbavancin is the first once a week antibiotic with activity against a broad range of Gram-positive pathogens. A large multicentre, pivotal, Phase III clinical trial, which included 854 patients ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Open Forum Infectious Diseases
سال: 2018
ISSN: 2328-8957
DOI: 10.1093/ofid/ofy210.1193